Kaplan-Meier survival curve analysis showed that ALL patients with high FBXO8 expression had significantly improved survival rates, whereas those with low FBXO8 expression had significantly worse outcomes, both in the training and validation cohorts (Figures 8A, B, p < 0.001). Here, FBXO8 is linked to acute lymphoblastic leukemia.